Nasrin, Shamima
Hegerle, Nicolas
Sen, Shaichi
Nkeze, Joseph
Sen, Sunil
Permala-Booth, Jasnehta
Choi, Myeongjin
Sinclair, James
Tapia, Milagritos D.
Johnson, J. Kristie
Sow, Samba O.
Thaden, Joshua T.
Fowler, Vance G. Jr
Krogfelt, Karen A.
Brauner, Annelie
Protonotariou, Efthymia
Christaki, Eirini
Shindo, Yuichiro
Kwa, Andrea L.
Shakoor, Sadia
Singh-Moodley, Ashika
Perovic, Olga
Jacobs, Jan
Lunguya, Octavie
Simon, Raphael
Cross, Alan S.
Tennant, Sharon M.
Article History
Received: 3 June 2021
Accepted: 6 December 2021
First Online: 6 January 2022
Declarations
:
: No human data were used in this study. Bacterial isolates were de-identified. This study was designated as non-human research by the University of Maryland Baltimore Institutional Review Board.
: Not applicable.
: SMT, RS and ASC are holders of US patents 9,988,426 and 10,556,931 titled “Broad spectrum conjugate vaccine to prevent <i>Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i> infections.” All other authors declare no competing interests.